BITTERFELD-WOLFEN, GERMANY--(MARKET WIRE)--Feb 24, 2009 -- Q-Cells SE / Annual accounts / Ad hoc: Q-Cells SE publishes preliminary figures for fiscal 2008
- Sales of EUR 1,251.3 million and EBIT of EUR 205.1 million - New member appointed to the Executive Board
Q-Cells SE (QCE; ISIN DE0005558662) has published the preliminary figures for fiscal 2008. In the past year, production of crystalline solar cells was increased to 570.4 Megawatt peak (MWp) (same period in the previous year: 389.2 MWp) and consequently by 47% compared with 2007. Production by all the Group's investments in thin-film technologies totalled 15.4 MWp, with Q-Cells' fully consolidated companies contributing approx. 4 MWp to this figure. As a result, the Group's total production stood at around 574 MWp. In 2008, sales increased by 46% to EUR 1,251.3 million (previous year: EUR 858.9 million), Q-Cells International's project business contributed EUR 91.9 million to this figure (2007: EUR 13.5 million). In the fourth quarter, Group sales therefore amounted to EUR 319.4 million, which equates to an increase of 13% compared with the same quarter in the previous year.
In 2008, earnings before interest and taxes (EBIT) amounted
to EUR
205.1 million in total (2007: EUR 197.0 million). Without
taking into
account the considerably increased start-up costs for the
(fully
consolidated) new technologies, Q-Cells achieved an EBIT
of EUR 224.4
million in its core business (including the one-off effect
of the
ramp-up costs for the factory in Malaysia) and consequently
an EBIT
margin of 17%. Operating income in the fourth quarter, which
was
heavily influenced by the sales crisis at the year end,
therefore
stood at EUR 32.2 million for the Group and EUR 35.3 million
for the
core business. This meant that the targets for operating
business,
which were revised in December last year, were met.
Net income in 2008 rose to ca. EUR 190.5 million and is consequently some 28% up on the figure for the previous year (EUR 148.4 million). Q-Cells International's project business accounted for a positive contribution to Group income of EUR 6.4 million in the first full business year.
Excluding the profit contribution from the stake in Renewable Energy Corporation ASA (REC), Q-Cells' net income for the year stood at EUR 140.2 million (2007: EUR 127.1 million).
For the current year, Q-Cells SE continues to expect production volume in the Group of between 800 MWp and 1 GWp. Including the contribution to sales by Q-Cells International's rapidly expanding project business, which has projects between 100 and 200 MWp in the planning stage, the Group is aiming to achieve sales of between EUR 1.7 and 2.1 billion (previous target EUR 1.75 to 2.25 billion).
In view of the company's development as well as the continuing globalisation and differentiation of the photovoltaic market, the existing Executive Board will be supplemented by an additional member. With effect from 1 April the Supervisory Board of Q-Cells has appointed Dr. Marko Schulz as fifth member of the Executive Board with responsibility for "Sales & Systems". The 44 year old, who among other things spent 13 years playing a leading role in projects in the energy and public sectors at McKinsey, has been responsible for the Group's project business as CEO of Q-Cells International since July 2007.
A presentation on the 2008 preliminary figures can be downloaded from the Investor Relations section of the Q-Cells SE's website (www.q-cells.de).
Contact information: Q-Cells SE OT Thalheim Guardianstraße 16 06766 Bitterfeld-Wolfen, Germany Investor Relations: Public Relations: Stefan Lissner Stefan Dietrich Phone: +49 - (0)3494 - 6699 10101 Phone: +49 - (0)3494 - 6699 10111 investor@q-cells.com presse@q-cells.com
Presentation Preliminary Figures 2008: http://hugin.info/136506/R/1292726/292541.pdf
Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement.
Copyright © Hugin AS 2009. All rights reserved.
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.